Genetic Determinants of Financial Risk Taking by Kuhnen, Camelia M. & Chiao, Joan Y.
Genetic Determinants of Financial Risk Taking
Camelia M. Kuhnen
1*, Joan Y. Chiao
2,3*
1Kellogg School of Management, Northwestern University, Evanston, Illinois, United States of America, 2Department of Psychology, Northwestern University, Evanston,
Illinois, United States of America, 3Northwestern University Interdepartmental Neuroscience Program, Evanston, Illinois, United States of America
Abstract
Individuals vary in their willingness to take financial risks. Here we show that variants of two genes that regulate dopamine
and serotonin neurotransmission and have been previously linked to emotional behavior, anxiety and addiction (5-HTTLPR
and DRD4) are significant determinants of risk taking in investment decisions. We find that the 5-HTTLPR s/s allele carriers
take 28% less risk than those carrying the s/l or l/l alleles of the gene. DRD4 7-repeat allele carriers take 25% more risk than
individuals without the 7-repeat allele. These findings contribute to the emerging literature on the genetic determinants of
economic behavior.
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Introduction
Risk preferences describe individuals’ willingness to take or
avoid risk in a variety of settings, including financial choice, and
are an essential component of any model of economic behavior.
Individuals vary in the extent to which they are willing to take
financial risks, which may be explained in part by individual
differences in heritable traits. Classical twin design studies estimate
that genetic effects account for 20% variation in risk taking in
experimental lottery choices [1] and between 35–54% of the
liability for developing symptoms of pathological gambling [2].
However, identification of specific genes underlying financial risk
preferences has remained elusive.
Recentfindingsinneurosciencesuggestthattheneurotransmitters
dopamine [3] and serotonin [4] have important roles in decision
making. Genes that regulate these neurotransmitters impact the
processing of information about rewarding [5–6] and harmful
stimuli [6–8], are related to personality traits such as extraversion
[9], novelty seeking [10] and anxiety [11], and are associated with
developing addictions [12]. Moreover, activity within the anterior
insula and the nucleus accumbens, brain regions innervated by
serotonergic and dopaminergic neural pathways, has been shown to
relate to individuals’ financial risk taking behavior [13].
Given the mounting evidence that the dopaminergic and
serotonergic systems are involved in decision making, and that
genetic variations have a significant effect on the physiology of
these two systems [14–15], we sought to understand whether such
genetic variations lead to individual differences in financial risk
taking preferences. Prior research suggests that variants of two
specific genes may be involved in risk and reward processing, and
therefore could influence financial risk taking: the serotonin
transporter polymorphism (5-HTTLPR) and dopamine D4
receptor (DRD4) exon III polymorphism. The 5-HTTLPR consists
of a 44-base pair insertion or deletion, generating either a long (l)
or a short (s) allele. The short variant of the polymorphism reduces
the transcriptional efficiency of the 5-HTT gene promoter and is
associated with higher scores on neuroticism and harm avoidance
[11]. The dopamine D4 receptor (DRD4) exon III polymorphism
has been linked to novelty seeking and pathological gambling.
Individuals with the 7-repeat allele have higher novelty seeking
scores than those with other DRD4 variants [10] and are more
likely to be pathological gamblers [16].
Here we investigated whether or not genetic variations in these
two candidate functional polymorphisms, 5-HTTLPR and DRD4,
contribute to individual differences in financial risk taking
preferences. Based on prior work, we hypothesized that individuals
carrying two copies of the s allele of the 5-HTTLPR would be
significantly more risk averse relative to individuals carrying one or
two copies of the l allele. Additionally, we hypothesized that
individuals with a 7-repeat allele of the DRD4 polymorphism
would be significantly more risk seeking relative to those
individuals without the 7-repeat allele.
We elicited financial risk preferences in an experimental setting
where participants made multiple investment decisions allocating
funds between a risky and a riskless asset, and were compensated
based on the performance of their chosen financial portfolio
(Fig. 1A). We subsequently genotyped participants for 5-HTTLPR
and DRD4 functional polymorphisms (see Supplement).
We found that individuals carrying two copies of the short allele
of the 5-HTTLPR are significantly more risk averse relative to
individuals carrying one or two copies of the long allele.
Additionally, individuals with the 7-repeat allele of DRD4 are
significantly more risk seeking relative to those individuals without
the 7-repeat allele. These findings provide novel evidence of a
genetic basis for financial choices.
Methods
65 subjects (26 male; M age=22.4 yrs; SD age: 4.9 yrs) com-
pleted the investment task and were subsequently genotyped for
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was conducted by ACGT Inc. (Wheeling, IL) (see Supplementary
Methods S1).
All participants were affiliated with Northwestern University
and were recruited via email announcements sent to the subject
pool maintained by the Kellogg School of Management at
Northwestern University. The experiment was programmed (and
data were collected) using the software package E-Prime. Five to
nine subjects were in the laboratory solving the investment task at
the same time, with each individual in a cubicle separated from the
rest of the participants. Participants gave informed consent prior to
participating and the study was approved by the IRB committee at
Northwestern University. The entire experiment took 1.5 hours to
complete and the average pay per subject was $25.
T h ee n t i r es a m p l ec o n s i s t e do f2 1c a r r i e r s( 8m a l e )h o m o z y g o u sf o r
the s allele, 44 carriers (18 male) with one or two copies of the l allele
of the 5-HTTLPR polymorphism (see Supplementary Table S1), 15
carriers (8 male) of the 7-repeat allele, and 50 non-carriers (18 male)
of 7-repeat allele variant of DRD4 (see Supplementary Table S2). We
conducted statistical analyses to compare expected versus observed
allele frequencies for our 5-HTTLPR sample (see Supplementary
Table S1) and found that 5-HTTLPR genotypes in our sample were
distributed according to Hardy-Weinberg equilibrium (Pearson chi-
square=0.39, df=1, p.0.05). Additionally, we conducted statistical
analyses for HW equilibrium of DRD4 genotypes (see Supplementary
Table S2) using the Markov Chain algorithm [17] and found that
DRD4 allele frequencies in the current sample were distributed
according to HWE (Markov chain algorithm; p=0.36).
Participants first completed the investment task and were then
genotyped. On each of the 96 trials (see Fig. 1A) of the task
subjects were given an amount of money $T. Subjects could invest
$T+$15 (the show-up fee) in two assets, a riskless and a risky one.
The amount not invested in the risky asset was automatically
invested in the riskless asset (shorting and borrowing were not
allowed). The trial endowment amount T was either $8 or $13,
and hence the amount subjects could invest (T+$15 show-up fee)
was either $23 or $28 per trial. In one version of the task, subjects
were informed that the risky asset would pay either of two possible
returns with equal probability, and these two possible outcomes for
the return were known by the subject in each trial. In another
version of the task, subjects were provided with the expected
return and standard deviation of the risky asset. These two ways of
presenting information about the payoffs of the risky investment
are equivalent if subjects have mean-variance preferences (i.e. they
like higher expected returns and lower variance), a common
assumption in the finance literature which is also supported by our
data. The riskless asset paid a known rate of return. Subjects’
choices did not differ across these versions of the task (completed
by 26 and 39 subjects, respectively), and therefore we combine the
data from the two versions.
Figure 1. (A) Trial structure of the investment task. For 6 seconds subjects observe the two possible and equally-likely values of the return of the
risky asset, the return of the safe asset and the amount they have to invest that trial. When the word ‘‘Choice’’ appears on the screen, subjects have
6 seconds to enter the amount they wish to invest in the risky asset. Their remaining funds are automatically invested in the safe asset. A 2-second
fixation screen precedes a new trial. (B) 5-HTTLPR and risk taking propensity. Individuals carrying one or two copies of the l allele demonstrated
significantly greater risk taking relative to individuals carrying two copies of the s allele (p,0.02). Error bars indicate standard errors. (C) DRD4 and risk
taking propensity. Individuals carrying the 7-repeat allele demonstrated significantly greater risk taking relative to individuals without the 7-repeat
allele (p,0.04). Error bars indicate standard errors.
doi:10.1371/journal.pone.0004362.g001
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return of the risk-free asset and the two possible outcomes of the
risky security, or, equivalently, the expected value and standard
deviation of the risky return. These values differed from trial to
trial, as did the amount of money available to the subject to invest.
The actual rate of return for the risky asset on any trial was not
revealed until the end of the experiment. At the end of the
experiment, each subject selected a random number between 1
and 96 by picking a ball from an urn. That number determined
the trial for which the subject would receive payment. If on any
trial a subject chose to invest in the risky asset an amount larger
that the maximum investment allowed ($T+$15), or if they did not
respond, that trial was marked as invalid. If an invalid trial was
selected from the urn, the final payment was only the show-up fee
of $15. Subjects therefore had incentives to always enter their
choice for the risky investment, and to treat each of the 96 trials as
the one that would determine their pay. By deferring information
about earnings until the end of the experiment we eliminate wealth
effects that may change subjects’ choices depending on past
outcomes.
In each trial subjects had six seconds to learn the information
about the return distribution of the risky security and the return of
the safe asset. They had six additional seconds to enter the dollar
amount they wished to invest in the risky asset, which was an
integer that could range from zero to the maximum investment of
$T+$15. A 2-second fixation screen indicated a new trial was
about to begin.
Results
The amount of money participants invested in the risky security
(M risky allocation: $9.78; SD risky allocation: $7.16) on each trial
depended on the characteristics of the two investment choices, as
would be predicted by standard models of economic choice where
individuals have mean-variance preferences [18]. Our benchmark
model of investment decisions (see Table 1) indicates that all else
equal, participants invested significantly more money in the risky
asset if its expected return was higher, the standard deviation of its
return was lower, or if the return of the safe asset was lower.
Moreover, the higher the amount available to participants, the
more money they invested in the risky asset. For each portfolio
allocation decision of our subjects we calculated the risky
investment in excess of the amount predicted by the benchmark
model (i.e. the residual term in the regression model in Table 1).
For each subject, we obtained the average across all 96 trials of this
residual investment. This average is the subject’s excess risky
investment and it measures how risk seeking an individual is relative
to the average person in the subject pool.
Results demonstrate that financial risk seeking is correlated with
the 5-HTTLPR and DRD4 functional polymorphisms. As shown in
Fig. 1B, individuals who carry two copies of the short allele of the
5-HTTLPR polymorphism invest $2.69 (about 28% of the average
risky allocation) less in the risky asset than those carrying one or
two copies of the long allele of the genotype (p,0.02 in a one-
tailed mean comparison test), in excess of the benchmark model.
Similarly, individuals who carry the 7-repeat allele in the DRD4
gene invest $2.46 (about 25% of the average risky allocation) more
in the risky asset than those lacking the 7-repeat allele (Fig. 1C,
p,0.04 in a one-tailed mean comparison test).
Discussion
Our findings show that two functional polymorphisms known to
regulate serotonergic and dopaminergic activity in the brain are
associated with individual differences in financial risk-seeking
behavior. Consistent with our results, a contemporaneous study
[19] showed in a male sample a positive correlation between the
presence of the 7-repeat allele of the D4DR and the propensity to
choose risky investment options using a similar experimental setup.
The current work complements a growing body of work demon-
strating the heritability of economic decision-making [12,20] and
reveals specific genetic determinants of financial choices. While the
effects that we document here are suggestive of a causal
relationship between individuals’ genotype and risk preferences,
our data do not allow for causality to be firmly established.
Prior work in behavioral genetics suggests an evolutionary
explanation for our findings. For instance, a seminal study [21]
found an association between long distance migration and the
proportion of long alleles of DRD4, suggesting that DRD4 is
important for novelty-seeking behaviors that may have adaptive
value [22]. However, the strength association between the DRD4
gene and novelty-seeking behavior may be variable [23]. For
instance, a recent behavioral genetics study found that the
presence of the 7R allele of the DRD4 is more advantageous
among nomadic relative to settled Ariaal men living in northern
Kenya [24]. Similarly, individuals carrying one or two copies of
the short allele of the 5-HTTLPR have been shown to be more
vulnerable to affective disorders (e.g., anxiety and depression)
when exposed to stressful experiences [25], suggesting an adaptive
benefit of carrying the long allele of the 5-HTTLPR. Here we
show that individuals who carry the long alleles of DRD4 and 5-
HTTLPR take greater financial risks. We speculate that financial
risk taking may result from evolutionarily adaptive mechanisms
that encourage novelty-seeking behavior, however future research
is needed to determine whether it leads to better economic
outcomes and evolutionary benefits, more broadly construed.
Table 1. Benchmark model of amount invested in risky asset.
Dependent Variable Amount invested in risky asset
Coefficient/t-stat
Risky Asset Expected Return 42.89
(9.20)***
Risky Asset Std Dev of Return 23.92
(22.55)**
Safe Asset Return 270.01
(27.81)***
Available funds 0.39
(7.34)***
Trial Number 20.01
(21.42)
Constant 22.66
(21.64)
Adj. R
2 0.13
Observations 5987
The dependent variable is the amount invested in the risky asset in each trial.
Independent variables include the characteristics of the two investment options
in a given trial, the amount of money available to the subject, as well as a task
version indicator variable. Standard errors are robust to heteroscedasticity and
correlation among error terms in observations belonging to the same subject.
T-statistics are in parentheses.
**p,0.05;
***p,0.01
doi:10.1371/journal.pone.0004362.t001
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Table S1 Allele and genotype frequencies for 5HTTLPR
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